To reach their full anti-cancer potential, cytotoxic agents like doxorubicin, epirubicin, paclitaxel, docetaxel, cisplatin, carboplatin, antimetabolites, 5-fluorouracil, capecitabine, and targeted therapies like trastuzumab and CDK4/6 inhibitors rely on precise dosing or predictable metabolic pathways, among other factors (201)
Therapy decisions are informed by clinical evaluation and, when required, laboratory data to ensure antioxidant support aligns with the individuals physiological demands rather than being applied generically
Group 2 was treated with HA, at a molecular weight of 3.010 Da and a concentration of 10 mg/mL, delivering a dose of 6 mg per injection
Caffeine wakes us up by blocking the adenosine receptor